<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-07-05" modified="2020-10-07" version="201">
<accession>Q14676</accession>
<accession>A2AB04</accession>
<accession>A2BF04</accession>
<accession>A2RRA8</accession>
<accession>A7YY86</accession>
<accession>B0S8A2</accession>
<accession>Q0EFC2</accession>
<accession>Q2L6H7</accession>
<accession>Q2TAZ4</accession>
<accession>Q5JP55</accession>
<accession>Q5JP56</accession>
<accession>Q5ST83</accession>
<accession>Q68CQ3</accession>
<accession>Q86Z06</accession>
<accession>Q96QC2</accession>
<name>MDC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mediator of DNA damage checkpoint protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Nuclear factor with BRCT domains 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MDC1</name>
<name type="synonym">KIAA0170</name>
<name type="synonym">NFBD1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="17" last="24">
<title>Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Ishikawa K."/>
<person name="Tanaka A."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="8724849"/>
<dbReference type="DOI" id="10.1093/dnares/3.1.17"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS MET-536; PRO-1540 AND ARG-1545</scope>
<source>
<tissue>Myelomonocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LYS-268</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="1999-09" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.</title>
<authorList>
<person name="Shiina S."/>
<person name="Tamiya G."/>
<person name="Oka A."/>
<person name="Inoko H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANTS LYS-251; ALA-586; ASP-1509; PRO-1540 AND ARG-1545</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Genetics" volume="173" first="1555" last="1570">
<title>Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity.</title>
<authorList>
<person name="Shiina T."/>
<person name="Ota M."/>
<person name="Shimizu S."/>
<person name="Katsuyama Y."/>
<person name="Hashimoto N."/>
<person name="Takasu M."/>
<person name="Anzai T."/>
<person name="Kulski J.K."/>
<person name="Kikkawa E."/>
<person name="Naruse T."/>
<person name="Kimura N."/>
<person name="Yanagiya K."/>
<person name="Watanabe A."/>
<person name="Hosomichi K."/>
<person name="Kohara S."/>
<person name="Iwamoto C."/>
<person name="Umehara Y."/>
<person name="Meyer A."/>
<person name="Wanner V."/>
<person name="Sano K."/>
<person name="Macquin C."/>
<person name="Ikeo K."/>
<person name="Tokunaga K."/>
<person name="Gojobori T."/>
<person name="Inoko H."/>
<person name="Bahram S."/>
</authorList>
<dbReference type="PubMed" id="16702430"/>
<dbReference type="DOI" id="10.1534/genetics.106.057034"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANTS LYS-371; LEU-386; PRO-1180; ASP-1509 AND ARG-1545</scope>
<source>
<tissue>Peripheral blood leukocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANTS LYS-268 AND ARG-1545</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT ARG-1545</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 279-2089 (ISOFORM 4)</scope>
<scope>VARIANTS MET-536; PRO-1540 AND ARG-1545</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="8586" last="8591">
<title>53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.</title>
<authorList>
<person name="Mochan T.A."/>
<person name="Venere M."/>
<person name="DiTullio R.A. Jr."/>
<person name="Halazonetis T.D."/>
</authorList>
<dbReference type="PubMed" id="14695167"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="6323" last="6329">
<title>NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response.</title>
<authorList>
<person name="Shang Y.L."/>
<person name="Bodero A.J."/>
<person name="Chen P.-L."/>
</authorList>
<dbReference type="PubMed" id="12475977"/>
<dbReference type="DOI" id="10.1074/jbc.m210749200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="8795" last="8803">
<title>NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways.</title>
<authorList>
<person name="Xu X."/>
<person name="Stern D.F."/>
</authorList>
<dbReference type="PubMed" id="12499369"/>
<dbReference type="DOI" id="10.1074/jbc.m211392200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ATM- AND CELL CYCLE-DEPENDENT PHOSPHORYLATION</scope>
<scope>DOMAINS NLS1 AND NLS2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="8873" last="8876">
<title>NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage.</title>
<authorList>
<person name="Peng A."/>
<person name="Chen P.-L."/>
</authorList>
<dbReference type="PubMed" id="12551934"/>
<dbReference type="DOI" id="10.1074/jbc.c300001200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CHEK2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="13599" last="13602">
<title>Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control.</title>
<authorList>
<person name="Lou Z."/>
<person name="Chini C.C.S."/>
<person name="Minter-Dykhouse K."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="12611903"/>
<dbReference type="DOI" id="10.1074/jbc.c300060200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BRCA1 AND BARD1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Nature" volume="421" first="952" last="956">
<title>MDC1 is required for the intra-S-phase DNA damage checkpoint.</title>
<authorList>
<person name="Goldberg M."/>
<person name="Stucki M."/>
<person name="Falck J."/>
<person name="D'Amours D."/>
<person name="Rahman D."/>
<person name="Pappin D."/>
<person name="Bartek J."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="12607003"/>
<dbReference type="DOI" id="10.1038/nature01445"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH THE MRN COMPLEX</scope>
<scope>PHOSPHORYLATION BY ATM</scope>
<scope>MUTAGENESIS OF ARG-58</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Nature" volume="421" first="957" last="961">
<title>MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.</title>
<authorList>
<person name="Lou Z."/>
<person name="Minter-Dykhouse K."/>
<person name="Wu X."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="12607004"/>
<dbReference type="DOI" id="10.1038/nature01447"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CHEK2</scope>
<scope>PHOSPHORYLATION BY ATM AND CHEK2</scope>
<scope>MUTAGENESIS OF ARG-58; SER-72; ASN-96; GLY-97 AND THR-98</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Nature" volume="421" first="961" last="966">
<title>MDC1 is a mediator of the mammalian DNA damage checkpoint.</title>
<authorList>
<person name="Stewart G.S."/>
<person name="Wang B."/>
<person name="Bignell C.R."/>
<person name="Taylor A.M.R."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="12607005"/>
<dbReference type="DOI" id="10.1038/nature01446"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH THE MRN COMPLEX; ATM; FANCD2; H2AX; SMC1A AND TP53BP1</scope>
<scope>PHOSPHORYLATION BY ATM</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="DNA Repair" volume="3" first="953" last="957">
<title>MDC1/NFBD1: a key regulator of the DNA damage response in higher eukaryotes.</title>
<authorList>
<person name="Stucki M."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="15279781"/>
<dbReference type="DOI" id="10.1016/j.dnarep.2004.03.007"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="2674" last="2683">
<title>Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention.</title>
<authorList>
<person name="Lukas C."/>
<person name="Melander F."/>
<person name="Stucki M."/>
<person name="Falck J."/>
<person name="Bekker-Jensen S."/>
<person name="Goldberg M."/>
<person name="Lerenthal Y."/>
<person name="Jackson S.P."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
</authorList>
<dbReference type="PubMed" id="15201865"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600269"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH H2AX</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="46359" last="46362">
<title>MDC1 regulates DNA-PK autophosphorylation in response to DNA damage.</title>
<authorList>
<person name="Lou Z."/>
<person name="Chen B.P.-C."/>
<person name="Asaithamby A."/>
<person name="Minter-Dykhouse K."/>
<person name="Chen D.J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="15377652"/>
<dbReference type="DOI" id="10.1074/jbc.c400375200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH THE PRKDC COMPLEX</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="1952" last="1967">
<title>Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction.</title>
<authorList>
<person name="Tang L.-Y."/>
<person name="Deng N."/>
<person name="Wang L.-S."/>
<person name="Dai J."/>
<person name="Wang Z.-L."/>
<person name="Jiang X.-S."/>
<person name="Li S.-J."/>
<person name="Li L."/>
<person name="Sheng Q.-H."/>
<person name="Wu D.-Q."/>
<person name="Li L."/>
<person name="Zeng R."/>
</authorList>
<dbReference type="PubMed" id="17693683"/>
<dbReference type="DOI" id="10.1074/mcp.m700120-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-372; SER-376; THR-378; SER-513; THR-523 AND SER-780</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Science" volume="318" first="1637" last="1640">
<title>Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase.</title>
<authorList>
<person name="Kolas N.K."/>
<person name="Chapman J.R."/>
<person name="Nakada S."/>
<person name="Ylanko J."/>
<person name="Chahwan R."/>
<person name="Sweeney F.D."/>
<person name="Panier S."/>
<person name="Mendez M."/>
<person name="Wildenhain J."/>
<person name="Thomson T.M."/>
<person name="Pelletier L."/>
<person name="Jackson S.P."/>
<person name="Durocher D."/>
</authorList>
<dbReference type="PubMed" id="18006705"/>
<dbReference type="DOI" id="10.1126/science.1150034"/>
</citation>
<scope>INTERACTION WITH RNF8</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="587" last="600">
<title>Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.</title>
<authorList>
<person name="Sivasubramaniam S."/>
<person name="Sun X."/>
<person name="Pan Y.R."/>
<person name="Wang S."/>
<person name="Lee E.Y."/>
</authorList>
<dbReference type="PubMed" id="18283122"/>
<dbReference type="DOI" id="10.1101/gad.1627708"/>
</citation>
<scope>INTERACTION WITH CEP164</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1403 AND THR-1425</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; THR-301; SER-394; SER-397; SER-402; THR-404; THR-449; SER-453; THR-455; SER-495; SER-498; SER-513; SER-780; SER-793; SER-1033; SER-1068; THR-1198; SER-1399; SER-1400; THR-1403; THR-1425; THR-1466; THR-1548; THR-1589; SER-1604; THR-1630; THR-1664; THR-1671; SER-1681; THR-1697; SER-1702; SER-1711; SER-1775 AND THR-1858</scope>
<scope>VARIANT [LARGE SCALE ANALYSIS] PRO-1540</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-329; THR-331; SER-372; SER-376; THR-378; SER-402; THR-404; SER-411; THR-449; SER-453; THR-455; THR-1157 AND THR-1466</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-812 AND LYS-1402</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="1489" last="1503">
<title>CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response.</title>
<authorList>
<person name="Becherel O.J."/>
<person name="Jakob B."/>
<person name="Cherry A.L."/>
<person name="Gueven N."/>
<person name="Fusser M."/>
<person name="Kijas A.W."/>
<person name="Peng C."/>
<person name="Katyal S."/>
<person name="McKinnon P.J."/>
<person name="Chen J."/>
<person name="Epe B."/>
<person name="Smerdon S.J."/>
<person name="Taucher-Scholz G."/>
<person name="Lavin M.F."/>
</authorList>
<dbReference type="PubMed" id="20008512"/>
<dbReference type="DOI" id="10.1093/nar/gkp1149"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH APTX</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-168; SER-329; THR-331; SER-402; THR-404; SER-485; SER-513; SER-955; SER-1068; SER-1399; THR-1403; THR-1425; THR-1589; SER-1775; THR-1800 AND SER-1820</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; THR-301; SER-329; SER-402; THR-404; THR-455; SER-495; SER-498; THR-1567 AND SER-1820</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="EMBO J." volume="31" first="3008" last="3019">
<title>Sumoylation of MDC1 is important for proper DNA damage response.</title>
<authorList>
<person name="Luo K."/>
<person name="Zhang H."/>
<person name="Wang L."/>
<person name="Yuan J."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="22635276"/>
<dbReference type="DOI" id="10.1038/emboj.2012.158"/>
</citation>
<scope>SUMOYLATION AT LYS-1840</scope>
<scope>UBIQUITINATION BY RNF4</scope>
<scope>MUTAGENESIS OF LYS-1840</scope>
<scope>INTERACTION WITH TP53BP1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; THR-146; SER-168; SER-299; SER-376; SER-453; THR-455; SER-485; SER-495; SER-498; SER-513; THR-523; SER-780; SER-998; SER-1086; THR-1157; SER-1399; SER-1400; THR-1403; THR-1425; SER-1564; THR-1589; THR-1671; SER-1775 AND SER-1820</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-168; SER-329; SER-485; SER-780; THR-1157; THR-1198; THR-1239; THR-1280; THR-1302 AND THR-1608</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1943</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1840</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-616 AND LYS-1413</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-616; LYS-1413; LYS-1740; LYS-1790 AND LYS-1840</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Cell" volume="123" first="1213" last="1226">
<title>MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.</title>
<authorList>
<person name="Stucki M."/>
<person name="Clapperton J.A."/>
<person name="Mohammad D."/>
<person name="Yaffe M.B."/>
<person name="Smerdon S.J."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="16377563"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.09.038"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) OF 1883-2089 IN COMPLEX WITH PHOSPHORYLATED H2AX</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="32053" last="32056">
<title>Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail.</title>
<authorList>
<person name="Lee M.S."/>
<person name="Edwards R.A."/>
<person name="Thede G.L."/>
<person name="Glover J.N.M."/>
</authorList>
<dbReference type="PubMed" id="16049003"/>
<dbReference type="DOI" id="10.1074/jbc.c500273200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 1891-2086</scope>
<scope>INTERACTION WITH PHOSPHORYLATED H2AX</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Structure" volume="18" first="167" last="176">
<title>Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.</title>
<authorList>
<person name="Campbell S.J."/>
<person name="Edwards R.A."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="20159462"/>
<dbReference type="DOI" id="10.1016/j.str.2009.12.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.33 ANGSTROMS) OF 1891-2089 IN COMPLEX WITH PHOSPHORYLATED HISTONE TETRAPEPTIDE</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="2854" last="2862">
<title>Molecular basis for the association of microcephalin (MCPH1) protein with the cell division cycle protein 27 (Cdc27) subunit of the anaphase-promoting complex.</title>
<authorList>
<person name="Singh N."/>
<person name="Wiltshire T.D."/>
<person name="Thompson J.R."/>
<person name="Mer G."/>
<person name="Couch F.J."/>
</authorList>
<dbReference type="PubMed" id="22139841"/>
<dbReference type="DOI" id="10.1074/jbc.m111.307868"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.33 ANGSTROMS) OF 1884-2089</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Nucleic Acids Res." volume="40" first="3898" last="3912">
<title>Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domain.</title>
<authorList>
<person name="Liu J."/>
<person name="Luo S."/>
<person name="Zhao H."/>
<person name="Liao J."/>
<person name="Li J."/>
<person name="Yang C."/>
<person name="Xu B."/>
<person name="Stern D.F."/>
<person name="Xu X."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="22234877"/>
<dbReference type="DOI" id="10.1093/nar/gkr1296"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1-10 AND 19-138</scope>
<scope>PHOSPHORYLATION AT THR-4</scope>
</reference>
<comment type="function">
<text evidence="26 27 28 29 30 31 32 34 35 36">Required for checkpoint mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle. May serve as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage marked by 'Ser-139' phosphorylation of histone H2AX. Also required for downstream events subsequent to the recruitment of these proteins. These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53 and apoptosis. ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1.</text>
</comment>
<comment type="subunit">
<text evidence="28 29 30 31 32 35 36 38 39 42 43 44 45 47">Homodimer. Interacts with several proteins involved in the DNA damage response, although not all these interactions may be direct. Interacts with H2AX, which requires phosphorylation of H2AX on 'Ser-139'. Interacts with the MRN complex, composed of MRE11, RAD50, and NBN. Interacts with CHEK2, which requires ATM-mediated phosphorylation of 'Thr-68' within the FHA domain of CHEK2. Interacts constitutively with the BRCA1-BARD1 complex, SMC1A and TP53BP1. Interacts with ATM and FANCD2, and these interactions are reduced upon DNA damage. Also interacts with the PRKDC complex, composed of XRCC6/KU70, XRCC5/KU80 and PRKDC/XRCC7. This interaction may be required for PRKDC autophosphorylation, which is essential for DNA double strand break (DSB) repair. When phosphorylated by ATM, interacts with RNF8 (via FHA domain). Interacts with CEP164. When phosphorylated, interacts with APTX (via FHA-like domain).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-495465">
<id>Q13315</id>
<label>ATM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-494830">
<id>P16104</id>
<label>H2AX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-495644">
<id>Q14676</id>
<label>MDC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-494844">
<id>O60934</id>
<label>NBN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>33</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-2693298">
<id>O96028</id>
<label>NSD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-15910280">
<id>O96028-1</id>
<label>NSD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-297202">
<id>Q06609</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-373337">
<id>O76064</id>
<label>RNF8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-15964690">
<id>O76064-1</id>
<label>RNF8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495644">
<id>Q14676</id>
</interactant>
<interactant intactId="EBI-2125045">
<id>O43070</id>
<label>nbs1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="26 27 28 29 30 31 32 34 35 36 44">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21">Chromosome</location>
</subcellularLocation>
<text>Associated with chromatin. Relocalizes to discrete nuclear foci following DNA damage, this requires 'Ser-139' phosphorylation of H2AX. Colocalizes with APTX at sites of DNA double-strand breaks.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14676-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14676-2</id>
<name>2</name>
<sequence type="described" ref="VSP_014593"/>
</isoform>
<isoform>
<id>Q14676-3</id>
<name>3</name>
<sequence type="described" ref="VSP_034104"/>
</isoform>
<isoform>
<id>Q14676-4</id>
<name>4</name>
<sequence type="described" ref="VSP_014593 VSP_034103"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="27">Highly expressed in testis.</text>
</comment>
<comment type="domain">
<text evidence="27">Tandemly repeated BRCT domains are characteristic of proteins involved in DNA damage signaling. In MDC1, these repeats are required for localization to chromatin which flanks sites of DNA damage marked by 'Ser-139' phosphorylation of H2AX.</text>
</comment>
<comment type="PTM">
<text evidence="29 30 31 46">Phosphorylated upon exposure to ionizing radiation (IR), ultraviolet radiation (UV), and hydroxyurea (HU). Phosphorylation in response to IR requires ATM, NBN, and possibly CHEK2. Also phosphorylated during the G2/M phase of the cell cycle and during activation of the mitotic spindle checkpoint. Phosphorylation at Thr-4 by ATM stabilizes and enhances homodimerization via the FHA domain.</text>
</comment>
<comment type="PTM">
<text evidence="47">Sumoylation at Lys-1840 by PIAS4 following DNA damage promotes ubiquitin-mediated degradation.</text>
</comment>
<comment type="PTM">
<text evidence="47">Ubiquitinated by RNF4, leading to proteasomal degradation; undergoes 'Lys-48'-linked polyubiquitination.</text>
</comment>
<comment type="sequence caution" evidence="52">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA11487" version="2"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="52">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="CAH18685" version="1"/>
</conflict>
<text>Truncated C-terminus.</text>
</comment>
<dbReference type="EMBL" id="D79992">
<property type="protein sequence ID" value="BAA11487.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR749828">
<property type="protein sequence ID" value="CAH18685.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BA000025">
<property type="protein sequence ID" value="BAB63322.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB088099">
<property type="protein sequence ID" value="BAC54931.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB202097">
<property type="protein sequence ID" value="BAE78617.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB103605">
<property type="protein sequence ID" value="BAF31266.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662797">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662848">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL845353">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BX248307">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BX927283">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR759873">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR788240">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR936878">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471081">
<property type="protein sequence ID" value="EAX03321.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110645">
<property type="protein sequence ID" value="AAI10646.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC152556">
<property type="protein sequence ID" value="AAI52557.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34384.1">
<molecule id="Q14676-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055456.2">
<molecule id="Q14676-1"/>
<property type="nucleotide sequence ID" value="NM_014641.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005249551.1">
<molecule id="Q14676-1"/>
<property type="nucleotide sequence ID" value="XM_005249494.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011513303.1">
<molecule id="Q14676-1"/>
<property type="nucleotide sequence ID" value="XM_011515001.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011513305.1">
<molecule id="Q14676-1"/>
<property type="nucleotide sequence ID" value="XM_011515003.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016867008.1">
<molecule id="Q14676-1"/>
<property type="nucleotide sequence ID" value="XM_017011519.1"/>
</dbReference>
<dbReference type="PDB" id="2ADO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A/B=1891-2086"/>
</dbReference>
<dbReference type="PDB" id="2AZM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="A/B=1883-2089"/>
</dbReference>
<dbReference type="PDB" id="2ETX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="A/B=1884-2089"/>
</dbReference>
<dbReference type="PDB" id="3K05">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="A/B=1891-2089"/>
</dbReference>
<dbReference type="PDB" id="3UEO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="E/F=325-336"/>
</dbReference>
<dbReference type="PDB" id="3UMZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=27-138"/>
</dbReference>
<dbReference type="PDB" id="3UN0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=26-138"/>
</dbReference>
<dbReference type="PDB" id="3UNM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=27-138"/>
</dbReference>
<dbReference type="PDB" id="3UNN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=27-138, B=1-8"/>
</dbReference>
<dbReference type="PDB" id="3UOT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=19-138, D/E=1-10"/>
</dbReference>
<dbReference type="PDBsum" id="2ADO"/>
<dbReference type="PDBsum" id="2AZM"/>
<dbReference type="PDBsum" id="2ETX"/>
<dbReference type="PDBsum" id="3K05"/>
<dbReference type="PDBsum" id="3UEO"/>
<dbReference type="PDBsum" id="3UMZ"/>
<dbReference type="PDBsum" id="3UN0"/>
<dbReference type="PDBsum" id="3UNM"/>
<dbReference type="PDBsum" id="3UNN"/>
<dbReference type="PDBsum" id="3UOT"/>
<dbReference type="SMR" id="Q14676"/>
<dbReference type="BioGRID" id="115014">
<property type="interactions" value="335"/>
</dbReference>
<dbReference type="CORUM" id="Q14676"/>
<dbReference type="DIP" id="DIP-33603N"/>
<dbReference type="IntAct" id="Q14676">
<property type="interactions" value="161"/>
</dbReference>
<dbReference type="MINT" id="Q14676"/>
<dbReference type="STRING" id="9606.ENSP00000365588"/>
<dbReference type="BindingDB" id="Q14676"/>
<dbReference type="iPTMnet" id="Q14676"/>
<dbReference type="PhosphoSitePlus" id="Q14676"/>
<dbReference type="SwissPalm" id="Q14676"/>
<dbReference type="BioMuta" id="MDC1"/>
<dbReference type="CPTAC" id="CPTAC-3234"/>
<dbReference type="CPTAC" id="CPTAC-3235"/>
<dbReference type="CPTAC" id="CPTAC-931"/>
<dbReference type="EPD" id="Q14676"/>
<dbReference type="jPOST" id="Q14676"/>
<dbReference type="MassIVE" id="Q14676"/>
<dbReference type="MaxQB" id="Q14676"/>
<dbReference type="PaxDb" id="Q14676"/>
<dbReference type="PeptideAtlas" id="Q14676"/>
<dbReference type="PRIDE" id="Q14676"/>
<dbReference type="ProteomicsDB" id="60105">
<molecule id="Q14676-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60106">
<molecule id="Q14676-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60107">
<molecule id="Q14676-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60108">
<molecule id="Q14676-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="1870">
<property type="antibodies" value="459 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="Q14676">
<property type="antibodies" value="5 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000376406">
<molecule id="Q14676-1"/>
<property type="protein sequence ID" value="ENSP00000365588"/>
<property type="gene ID" value="ENSG00000137337"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000383566">
<property type="protein sequence ID" value="ENSP00000373060"/>
<property type="gene ID" value="ENSG00000206481"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420019">
<molecule id="Q14676-1"/>
<property type="protein sequence ID" value="ENSP00000396484"/>
<property type="gene ID" value="ENSG00000224587"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420320">
<molecule id="Q14676-1"/>
<property type="protein sequence ID" value="ENSP00000416511"/>
<property type="gene ID" value="ENSG00000225589"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000427406">
<molecule id="Q14676-1"/>
<property type="protein sequence ID" value="ENSP00000387429"/>
<property type="gene ID" value="ENSG00000234012"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000435664">
<property type="protein sequence ID" value="ENSP00000404318"/>
<property type="gene ID" value="ENSG00000231135"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000440369">
<molecule id="Q14676-1"/>
<property type="protein sequence ID" value="ENSP00000415212"/>
<property type="gene ID" value="ENSG00000228575"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000449153">
<molecule id="Q14676-1"/>
<property type="protein sequence ID" value="ENSP00000409167"/>
<property type="gene ID" value="ENSG00000237095"/>
</dbReference>
<dbReference type="GeneID" id="9656"/>
<dbReference type="KEGG" id="hsa:9656"/>
<dbReference type="UCSC" id="uc003nrg.5">
<molecule id="Q14676-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9656"/>
<dbReference type="DisGeNET" id="9656"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000137337.14"/>
<dbReference type="GeneCards" id="MDC1"/>
<dbReference type="HGNC" id="HGNC:21163">
<property type="gene designation" value="MDC1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137337">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="607593">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14676"/>
<dbReference type="OpenTargets" id="ENSG00000137337"/>
<dbReference type="PharmGKB" id="PA134942837"/>
<dbReference type="eggNOG" id="KOG2043">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161757"/>
<dbReference type="HOGENOM" id="CLU_003038_0_0_1"/>
<dbReference type="InParanoid" id="Q14676"/>
<dbReference type="KO" id="K20780"/>
<dbReference type="OMA" id="HGDCETD"/>
<dbReference type="OrthoDB" id="670424at2759"/>
<dbReference type="PhylomeDB" id="Q14676"/>
<dbReference type="TreeFam" id="TF329580"/>
<dbReference type="PathwayCommons" id="Q14676"/>
<dbReference type="Reactome" id="R-HSA-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="SignaLink" id="Q14676"/>
<dbReference type="SIGNOR" id="Q14676"/>
<dbReference type="BioGRID-ORCS" id="9656">
<property type="hits" value="119 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MDC1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q14676"/>
<dbReference type="GeneWiki" id="MDC1"/>
<dbReference type="GenomeRNAi" id="9656"/>
<dbReference type="Pharos" id="Q14676">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14676"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="Q14676">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137337">
<property type="expression patterns" value="Expressed in testis and 225 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14676">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14676">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070975">
<property type="term" value="F:FHA domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006303">
<property type="term" value="P:double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031573">
<property type="term" value="P:intra-S DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00060">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="IDEAL" id="IID00568"/>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000253">
<property type="entry name" value="FHA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00498">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16770">
<property type="entry name" value="RTT107_BRCT_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00240">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50006">
<property type="entry name" value="FHA_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Mediator of DNA damage checkpoint protein 1" id="PRO_0000096316">
<location>
<begin position="1"/>
<end position="2089"/>
</location>
</feature>
<feature type="domain" description="FHA" evidence="25">
<location>
<begin position="54"/>
<end position="105"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="24">
<location>
<begin position="1892"/>
<end position="1970"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="24">
<location>
<begin position="1991"/>
<end position="2082"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CHEK2">
<location>
<begin position="1"/>
<end position="150"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the MRN complex">
<location>
<begin position="2"/>
<end position="220"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization (NLS1)">
<location>
<begin position="145"/>
<end position="568"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the PRKDC complex">
<location>
<begin position="1148"/>
<end position="1610"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization (NLS2)">
<location>
<begin position="1698"/>
<end position="2089"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="1034"/>
<end position="1469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ATM" evidence="46">
<location>
<position position="4"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 15 17">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="146"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 12 13 15 17">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 14 15">
<location>
<position position="299"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 14">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 13 14 17">
<location>
<position position="329"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 13">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 12">
<location>
<position position="372"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 12 15">
<location>
<position position="376"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 12">
<location>
<position position="378"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="394"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="397"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 12 13 14">
<location>
<position position="402"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 12 13 14">
<location>
<position position="404"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="411"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 12">
<location>
<position position="449"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 12 15">
<location>
<position position="453"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 12 14 15">
<location>
<position position="455"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 15 17">
<location>
<position position="485"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 14 15">
<location>
<position position="495"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 14 15">
<location>
<position position="498"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="504"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 13 15">
<location>
<position position="513"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 15">
<location>
<position position="523"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="590"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 15 17">
<location>
<position position="780"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="793"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="812"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="955"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="998"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13">
<location>
<position position="1068"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1086"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 15 17">
<location>
<position position="1157"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 17">
<location>
<position position="1198"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="1235"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="1239"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="1280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="1302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13 15">
<location>
<position position="1399"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 15">
<location>
<position position="1400"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="1402"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 10 13 15">
<location>
<position position="1403"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 10 13 15">
<location>
<position position="1425"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 12">
<location>
<position position="1466"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1548"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1564"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="1567"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 13 15">
<location>
<position position="1589"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1604"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="1608"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1630"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1664"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 15">
<location>
<position position="1671"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1681"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1697"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1702"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1711"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13 15">
<location>
<position position="1775"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="1800"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 14 15">
<location>
<position position="1820"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1858"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="16">
<location>
<position position="1943"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="18">
<location>
<position position="616"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20">
<location>
<position position="616"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="18">
<location>
<position position="1413"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20">
<location>
<position position="1413"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="1740"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="1790"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="47">
<location>
<position position="1840"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 20">
<location>
<position position="1840"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_014593" evidence="51">
<location>
<begin position="741"/>
<end position="1004"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_034103" evidence="51">
<location>
<begin position="1029"/>
<end position="1787"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_034104" evidence="51">
<location>
<begin position="1124"/>
<end position="1410"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28986464." id="VAR_051160">
<original>R</original>
<variation>C</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2517560." id="VAR_022843" evidence="49">
<original>E</original>
<variation>K</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9262152." id="VAR_022844" evidence="33 41">
<original>R</original>
<variation>K</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2075015." id="VAR_022845" evidence="40">
<original>E</original>
<variation>K</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28986465." id="VAR_051161" evidence="40">
<original>P</original>
<variation>L</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs58344693." id="VAR_043922" evidence="37 48">
<original>I</original>
<variation>M</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2844707." id="VAR_022846" evidence="49">
<original>S</original>
<variation>A</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28986467." id="VAR_051162">
<original>R</original>
<variation>S</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28994869." id="VAR_051163">
<original>P</original>
<variation>A</variation>
<location>
<position position="1100"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28987085." id="VAR_051164">
<original>S</original>
<variation>F</variation>
<location>
<position position="1112"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9461623." id="VAR_051165" evidence="40">
<original>S</original>
<variation>P</variation>
<location>
<position position="1180"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3132589." id="VAR_022847" evidence="40 49">
<original>E</original>
<variation>D</variation>
<location>
<position position="1509"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3130645." id="VAR_022848" evidence="10 37 48 49">
<original>S</original>
<variation>P</variation>
<location>
<position position="1540"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17292678." id="VAR_043923" evidence="33 37 40 48 49 50">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1545"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28994871." id="VAR_051166">
<original>P</original>
<variation>R</variation>
<location>
<position position="1745"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28994873." id="VAR_051167">
<original>V</original>
<variation>E</variation>
<location>
<position position="1791"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28994874." id="VAR_051168">
<original>D</original>
<variation>E</variation>
<location>
<position position="1855"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28994875." id="VAR_051169">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1883"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28994876." id="VAR_051170">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1904"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to the MRE11 complex and to CHEK2." evidence="29 30">
<original>R</original>
<variation>A</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to CHEK2." evidence="30">
<original>S</original>
<variation>A</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to CHEK2; when associated with A-97 and A-98." evidence="30">
<original>N</original>
<variation>A</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to CHEK2; when associated with A-96 and A-98." evidence="30">
<original>G</original>
<variation>A</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to CHEK2; when associated with A-96 and A-97." evidence="30">
<original>T</original>
<variation>A</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Suppresses RNF4-mediated ubiquitination, accumulates at sites of DNA damage, defective homologous recombination." evidence="47">
<original>K</original>
<variation>R</variation>
<location>
<position position="1840"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18685." ref="2" evidence="52">
<original>L</original>
<variation>P</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18685." ref="2" evidence="52">
<location>
<begin position="645"/>
<end position="1326"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAB63322." ref="3" evidence="52">
<original>G</original>
<variation>GS</variation>
<location>
<position position="1005"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA11487 and 7; AAI52557." ref="1 7" evidence="52">
<original>T</original>
<variation>A</variation>
<location>
<position position="1041"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAE78617." ref="4" evidence="52">
<original>Y</original>
<variation>S</variation>
<location>
<position position="1266"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAE78617." ref="4" evidence="52">
<original>P</original>
<variation>T</variation>
<location>
<position position="1283"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAC54931/BAF31266." ref="4" evidence="52">
<original>A</original>
<variation>T</variation>
<location>
<position position="1533"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BX248307." ref="5" evidence="52">
<original>E</original>
<variation>A</variation>
<location>
<position position="1536"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAE78617." ref="4" evidence="52">
<original>T</original>
<variation>S</variation>
<location>
<position position="1664"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18685." ref="2" evidence="52">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1668"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAE78617." ref="4" evidence="52">
<original>A</original>
<variation>T</variation>
<location>
<position position="1734"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="52">
<original>E</original>
<variation>K</variation>
<location>
<position position="1843"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="52">
<original>H</original>
<variation>R</variation>
<location>
<position position="2048"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="21"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="32"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="39"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="45"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="51"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="62"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="76"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="98"/>
<end position="100"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="101"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="120"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="126"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1894"/>
<end position="1897"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1903"/>
<end position="1911"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1920"/>
<end position="1922"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1924"/>
<end position="1927"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1935"/>
<end position="1943"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1951"/>
<end position="1959"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1966"/>
<end position="1968"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1973"/>
<end position="1978"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1983"/>
<end position="1992"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1995"/>
<end position="1998"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2000"/>
<end position="2003"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2011"/>
<end position="2020"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2024"/>
<end position="2026"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2037"/>
<end position="2040"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2043"/>
<end position="2048"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2050"/>
<end position="2055"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2063"/>
<end position="2071"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2076"/>
<end position="2079"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ETX"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3K05"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UMZ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UN0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UOT"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17693683"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000250"/>
<evidence key="22" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5PSV9"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5U2M8"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00086"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12475977"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12499369"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12551934"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12607003"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12607004"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12607005"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12611903"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14574404"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14695167"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15201865"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15377652"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16049003"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16377563"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16702430"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18006705"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18283122"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20008512"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20159462"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22234877"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22635276"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8724849"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="50" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<sequence length="2089" mass="226666" checksum="A8B880A25617EC96" modified="2005-07-05" version="3">MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

